CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells

Pathology International

Volumn 57, Issue 5, 2007, Pages 245-250

  Hasegawa, Masaki ^a,b   Hagiwara, Sumitaka ^a   Sato, Tomoko ^a   Jijiwa, Mayumi ^a   Murakumo, Yoshiki ^a   Maeda, Masahiro ^c   Moritani, Suzuko ^b   Ichihara, Shu ^b   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c Immuno Biological Laboratories Co Ltd   (Japan)

Author keywords

Basal cells; CD109; Immunohistochemistry; Lacrimal gland; Mammary gland; Myoepithelial cells; Prostate; Salivary gland

Indexed keywords

ALPHA 2 MACROGLOBULIN; PARAFFIN; PROTEIN CD109; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL; BREAST CARCINOMA; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN CELL; LACRIMAL GLAND; MAMMARY GLAND; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; SALIVARY GLAND; STAINING;

ANTIGENS, CD; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS; MALE; MAMMARY GLANDS, HUMAN; NEOPLASM PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; RNA INTERFERENCE; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TRANSFECTION;

EID: 34247168696     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02097.x     Document Type: Article

References (29)

1. 2 macroglobulin/C3,C4,C5 family of thioester-containing proteins. Blood 2002; 99: 1683-91.
2. Hashimoto M, Ichihara M, Watanabe T et al. Expression of CD109 in human cancer. Oncogene 2004; 23: 3716-20.
3. Asai N, Jijiwa M, Enomoto A et al. RET receptor signaling: Dysfunction in thyroid cancer and Hirschsprung's disease. Pathol Int 2006; 56: 164-72.
4. Zhang J-M, Hashimoto M, Kawai K et al. CD109 expression in squamous cell carcinoma of the uterine cervix. Pathol Int 2005; 55: 165-9.
5. Enomoto A, Murakami H, Asai N et al. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 2005; 9: 389-402.
6. Finnson KW, Tam BY, Liu K et al. Identification of CD109 as part of the TGF-β1 receptor system in human keratinocytes. FASEB J 2006; 20: 1525-7.
7. Barbareschi M, Pecciarini L, Cangi MG et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001; 25: 1054-60.
8. Ribeiro-Silva A, Zambelli Ramalho LN, Britto Garcia S et al. The relationship between p63 and p53 expression in normal and neoplastic breast tissue. Arch Pathol Laboratory Med J 2003; 127: 336-40.
9. Batistatou A, Stefanou D, Arkoumani E et al. The usefulness of p63 as a marker of breast myoepithelial cells. In Vivo 2003; 17: 573-6.
10. Werling RW, Hwang H, Yaziji H et al. Immunohistochemical distinction of invasive from noninvasive breast lesions: A comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 2003; 27: 82-90.
11. Bocker W, Bier B, Freytag G et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Vichows Arch A Pathol Anat Histopathol 1992; 421: 323-30.
12. Bassler R, Katzer B. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases. Virchows Arch A Pathol Anat Histopathol 1992; 421: 435-42.
13. Guelstein VI, Tchypysheva TA, Ermilova VD et al. Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. Int J Cancer 1993; 53: 269-77.
14. Egan MJ, Newman J, Crocker J et al. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast. Arch Pathol Lab Med 1987; 111: 28-31.
15. Umekita Y, Fujiyoshi T, Takasaki T et al. Immunohistochemical studies of S-100 protein expression in myoepithelial cells of benign breast diseases and normal breast tissues. In Vivo 1993; 7: 415-18.
16. Gugliotta P, Sapino A, Macri L et al. Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochem Cytochem 1988; 36: 659-63.
17. Bocker W, Bier B, Freytag G et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions. Virchows Arch A Pathol Anat Histopathol 1992; 421: 315-22.
18. Deugnier MA, Moiseyeva EP, Thiery JP et al. Myoepithelial cell differentiation in the developing mammary gland: Progressive acquisition of smooth muscle phenotype. Dev Dyn 1995; 204: 107-17.
19. Foschini MP, Scarpellini F, Gown AM et al. Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol 2000; 8: 29-37.
20. Reis-Filho JS, Milanezi F, Schmitt FC. Maspin is expressed in the nuclei of breast myoepithelial cells. J Pathol 2002; 197: 272-3.
21. Moritani S, Kushima R, Sugihara H et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 2002; 15: 397-405.
22. Kalof AN, Tam D, Beatty B et al. Immunostaining patterns of myoepithelial cells in breast lesions: A comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol 2004; 57: 625-9.
23. Popnikolov NK, Cavone SM, Schultz PM et al. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells. Mod Pathol 2005; 18: 1535-41.
24. Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol 1995; 19: 251-60.
25. Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol 1999; 12: 472-8.
26. Signoretti S, Waltregny D, Dilks J et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000; 157: 1769-75.
27. Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate?: An immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Am J Surg Pathol 2002; 26: 1151-60.
28. Shah RB, Zhou M, LeBlanc M et al. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002; 26: 1161-8.
29. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol 2002; 15: 1302-8.